M. Magni

M. Boccadoro, M. Ladetto, D. Drandi, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.

M. Ladetto, M. Di Nicola, D. Caracciolo, 2016, International journal of radiation oncology, biology, physics.

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.

C. Carlo-Stella, M. Di Nicola, F. Formelli, 2006, Cancer research.

Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.

G. Bonadonna, M. Di Nicola, S. Siena, 1992, Blood.

Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.

A. Anichini, C. Carlo-Stella, M. Di Nicola, 2003, Haematologica.

Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.

C. Carlo-Stella, M. Di Nicola, F. Ravagnani, 2012, American journal of blood research.

targets of retroviral-mediated gene transfer Human peripheral blood hematopoietic progenitors are optimal

G. Bonadonna, S. Siena, A. Gianni, 2011 .

Quantization of CD34+ Peripheral Blood Hematopoietic Progenitors for Autografting in Cancer Patients

G. Bonadonna, M. Di Nicola, S. Siena, 1993, The International journal of artificial organs.

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

A. Pileri, G. Bonadonna, M. Di Nicola, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Practical aspects of flow cytometry to guide large-scale collection of circulating hematopoietic progenitors for autologous transplantation in cancer patients

G. Bonadonna, S. Siena, F. Ravagnani, 1992 .

Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)

P. Strippoli, L. Bonsi, S. Siena, 1993, Stem cells.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis

C. Carlo-Stella, P. Valagussa, M. Di Nicola, 2014, Bone Marrow Transplantation.

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization

A. Pileri, A. Gallamini, D. Caracciolo, 2002, Bone Marrow Transplantation.

Large‐scale feasibility of gene transduction into human CD34+ cell‐derived dendritic cells by adenoviral/polycation complex

R. Tomanin, A. Anichini, C. Carlo-Stella, 2000, British journal of haematology.

Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes.

R. Tomanin, C. Carlo-Stella, M. Di Nicola, 1999, Human gene therapy.

Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor.

C. Carlo-Stella, M. Di Nicola, F. Formelli, 2004, Experimental hematology.

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.

G. Bonadonna, P. Valagussa, M. Di Nicola, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.

G. Bonadonna, M. Di Nicola, S. Siena, 1994, Bone marrow transplantation.

Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.

A. Anichini, M. Di Nicola, G. Sutter, 1998, Cancer gene therapy.

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

P. Corradini, A. Guidetti, L. Farina, 2016 .

Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.

S. Pilotti, J. Rosai, C. Bifulco, 2002, Leukemia research.

Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma

A. Rossi, G. Pizzolo, A. Gallamini, 2007 .

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

T. Barbui, C. Carlo-Stella, M. Martelli, 2009, Bone Marrow Transplantation.

ituximab Induces Effective Clearance of Minimal esidual Disease in Molecular Relapses of Mantle ell Lymphoma

M. Boccadoro, M. Ladetto, D. Drandi, 2006 .

Radioimmunotherapy and secondary leukemia: a case report.

A. Carbone, C. Carlo-Stella, M. Di Nicola, 2010, Leukemia research.

Successful second autologous engraftment after long duration storage of hematopoietic stem cells

F. Ravagnani, V. Montefusco, M. Milanesi, 2013, Bone Marrow Transplantation.

induced by cellular or nonspecific mitogenic stimuli Human bone marrow stromal cells suppress T-lymphocyte proliferation

C. Carlo-Stella, S. Grisanti, M. Milanesi, 2013 .

Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody.

C. Carlo-Stella, M. Di Nicola, A. Gianni, 2002, Blood.

Plasma membrane hyperpolarization and [Ca2+]i increase induced by fibroblast growth factor in NIH-3T3 fibroblasts: resemblance to early signals generated by platelet-derived growth factor.

J. Meldolesi, A. Pandiella, M. Magni, 1989, Biochemical and biophysical research communications.

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.

M. Di Nicola, A. Gianni, M. Magni, 2014, Future oncology.

Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.

C. Carlo-Stella, M. Di Nicola, F. Formelli, 2002, Cancer research.

Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.

A. Carbone, A. Gloghini, C. Carlo-Stella, 2006, Human gene therapy.

High response rate and manageable toxicity with an intensive, short‐term chemotherapy programme for Burkitt's lymphoma in adults

C. Carlo-Stella, M. Massimino, A. Guidetti, 2004, British journal of haematology.

Phospholipid Hydrolysis and [Ca2+]i Control

E. Clementi, J. Meldolesi, G. Gatti, 1993 .

Patients with high‐risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting

M. Boccadoro, A. Pileri, M. Dell'aquila, 2003, Cancer.

Ionic events induced by epidermal growth factor. Evidence that hyperpolarization and stimulated cation influx play a role in the stimulation of cell growth.

J. Meldolesi, A. Pandiella, M. Magni, 1991, The Journal of biological chemistry.

The effect of epidermal growth factor on membrane potential. Rapid hyperpolarization followed by persistent fluctuations.

J. Meldolesi, A. Pandiella, M. Magni, 1989, The Journal of biological chemistry.

Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.

C. Carlo-Stella, M. Di Nicola, A. Guidetti, 2006, Haematologica.

Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.

S. Shammah, W. Mellado, A. Gianni, 1996, Blood.

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

A. Anichini, C. Carlo-Stella, M. Di Nicola, 2009, Blood.

Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene.

L. Naldini, P. Comoglio, L. Munaron, 1991, The Journal of biological chemistry.

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.

C. Carlo-Stella, M. Di Nicola, F. Formelli, 2004, Blood.

IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.

A. Carbone, C. Carlo-Stella, M. Di Nicola, 2007, Cancer research.

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.

A. Pileri, G. Bonadonna, M. Di Nicola, 2000, Blood.

Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience

C. Carlo-Stella, P. Valagussa, M. Di Nicola, 2010, Leukemia & lymphoma.

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.

A. Rossi, M. Di Nicola, A. Gallamini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis

G. Merlini, S. Casarini, V. Perfetti, 1999, Bone Marrow Transplantation.

Safety, Tolerability and Activity of Ofatumumab, Bendamustine and Dexamethasone Combination As First-Line Treatment of Mantle-Cell Lymphoma in the Elderly: A Multicenter Study

C. Carlo-Stella, V. Rizzoli, A. Gallamini, 2011 .

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

M. Ladetto, F. Ciceri, F. Raimondo, 2013 .

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

M. Boccadoro, M. Ladetto, A. Gallamini, 2007, Leukemia.

Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up

C. Carlo-Stella, A. Guidetti, M. Magni, 2010, Bone Marrow Transplantation.

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

C. Carlo-Stella, M. Di Nicola, E. Seregni, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab: enhancing stem cell transplantation in mantle cell lymphoma

M. Martelli, S. Cortelazzo, M. Magni, 2002, Bone Marrow Transplantation.

Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination

M. Del Vecchio, N. Cascinelli, A. Anichini, 2004, Clinical Cancer Research.

Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK- fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells.

J. Meldolesi, P. Albert, O. Civelli, 1990, The Journal of biological chemistry.

Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas

C. Croce, M. Iorio, N. Zaffaroni, 2014, International journal of cancer.

Placental Growth Factor‐1 Potentiates Hematopoietic Progenitor Cell Mobilization Induced by Granulocyte Colony‐Stimulating Factor in Mice and Nonhuman Primates

F. Colotta, C. Carlo-Stella, M. Di Nicola, 2007, Stem cells.

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

P. Pedrazzoli, R. Miceli, C. Carlo-Stella, 2014, Clinical genitourinary cancer.

Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis

M. Boccadoro, M. Ladetto, A. Gallamini, 2004 .

Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.

T. Barbui, M. Boccadoro, A. Pileri, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with a Patient-Adapted Approach to Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis

G. Merlini, S. Siena, G. Palladini, 2004 .

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

A. Rossi, M. Ladetto, A. Ferreri, 2021, Bone Marrow Transplantation.

chemotherapy and anti-CD20 monoclonal antibody Leukoencephalopathy and papovavirus infection after treatment with

C. Carlo-Stella, A. Gianni, M. Magni, 2011 .

P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patients

T. Barbui, M. Boccadoro, A. Gallamini, 2007 .

Incidence of Secondary Myelodysplastic Syndrome/Acute Leukemia in 1,266 Lymphoma Patients Following High-Dose Therapy and Autograft: A Study from GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

T. Barbui, M. Boccadoro, A. Gallamini, 2006 .

In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3.

C. Carlo-Stella, F. Formelli, M. Milanesi, 2004 .

Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.

L. Baldini, U. Gianelli, A. Guffanti, 2004, Haematologica.

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.

G. Bonadonna, M. Di Nicola, S. Siena, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

DIFFERENTIAL COUPLING OF DOPAMINERGIC D2 RECEPTORS EXPRESSED INDIFFERENT CELL TYPES

J. Meldolesi, P. Albert, O. Civelli, 1990 .

High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.

G. Bonadonna, P. Valagussa, M. Di Nicola, 2001, European journal of haematology. Supplementum.

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).

T. Barbui, A. Rossi, M. Boccadoro, 2006 .

Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas

C. Croce, M. Iorio, N. Zaffaroni, 2014, International journal of cancer.

Benefit of Rituximab Addition to High-Dose Programs with Autograft for B-Cell Lymphoma: A Multicenter GITIL Survey on 957 Patients.

T. Barbui, M. Boccadoro, G. Pizzolo, 2006 .

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.

C. Carlo-Stella, P. Valagussa, E. Seregni, 2006 .

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

A. Anichini, C. Carlo-Stella, M. Di Nicola, 2009, Blood.

Lipid metabolites and growth factor action.

J. Meldolesi, M. Magni, 1991, Trends in pharmacological sciences.